Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03722992 · ClinicalTrials.gov registry record · NA

The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients

A NA study of Interstitial Cystitis, sponsored by TriHealth.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT03722992 is a NA study of Interstitial Cystitis that has completed, run by TriHealth. The registered enrollment target is 14 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03722992, a NA study of Interstitial Cystitis, has completed, sponsored by TriHealth.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.

Conditions Studied

Interventions

  • OTHER MBSR

Study Locations (1)

Ohio

  • TriHealth - Cincinnati Urogynecology Associates - Cincinnati

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-03-07
Est. Completion 2020-03-15
Phase NA

Sponsor

TriHealth

81 total trials

What the Registry Record Tells You About NCT03722992

The ClinicalTrials.gov registry entry for NCT03722992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 1 intervention - of which MBSR is the first listed.

NCT03722992 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03722992 about?

NCT03722992 is a clinical study titled "The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients". This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.

What is the current status of trial NCT03722992?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-03-07. Estimated completion is 2020-03-15.

What conditions does trial NCT03722992 study?

This clinical trial studies the following conditions: Interstitial Cystitis.

What interventions are being tested in trial NCT03722992?

The interventions under investigation include: MBSR (OTHER).

Who is sponsoring clinical trial NCT03722992?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03722992 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.